Drishya Kurup

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

NPJ vaccines

Viruses

PLoS pathogens

Journal of immunology (Baltimore, Md. : 1950)

Thomas Jefferson University

Thomas Jefferson University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University May 24 2020

United States

POSTDOCTORAL FELLOW :: MICROBIOLOGY AND IMMUNOLOGY

Education History

Thomas Jefferson University Sep 05 2015 - May 20 2020

United States

PHD :: Microbiology and Immunology

Publications

Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Sabrine Ben Hamed, Jacob F Myers, Anisha Chandwani, Christoph Wirblich, Drishya Kurup, Nir Paran, Matthias J Schnell
Toward the Development of a Pan-Lyssavirus Vaccine. Viruses 16 (7) (2024)
Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole M Josleyn, Eric R Wilkinson, Jay Wells, Jesse Steffens, Ginger Lynn, Sean Vantongeren, Xiankun Zeng, Nancy Twenhafel, Kathleen A Cashman, Matthias J Schnell
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease. NPJ vaccines 9 (1) (2024)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich, Matthias J Schnell
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. NPJ vaccines 8 (1) (2023)
Drishya Kurup, Christoph Wirblich, Rachael Lambert, Leila Zabihi Diba, Benjamin E Leiby, Matthias J Schnell
Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. NPJ vaccines 7 (1) (2022)
Catherine Yankowski, Christoph Wirblich, Drishya Kurup, Matthias J Schnell
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity. NPJ vaccines 7 (1) (2022)
Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, Adam J Ronk, Chad E Mire, Natalia Kuzmina, Noor Shaik, Sivakumar Periasamy, Matthew A Hyde, Julie M Williams, Pei-Yong Shi, Matthias J Schnell, Alexander Bukreyev
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. NPJ vaccines 6 (1) (2021)
Drishya Kurup, Delphine C Malherbe, Christoph Wirblich, Rachael Lambert, Adam J Ronk, Leila Zabihi Diba, Alexander Bukreyev, Matthias J Schnell
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. PLoS pathogens 17 (3) (2021)
Drishya Kurup, Christoph Wirblich, Holly Ramage, Matthias J Schnell
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2. NPJ vaccines 5 (2020)
Sofia Caldeira-Dantas, Thomas Furmanak, Corinne J Smith, Michael Quinn, Leyla Y Teos, Adam Ertel, Drishya Kurup, Mayank Tandon, Ilias Alevizos, Christopher M Snyder
The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection. Journal of immunology (Baltimore, Md. : 1950) 200 (3) (2017)

Drishya Kurup.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Drishya Kurup